Abstract:Abstract Background Due to the global occurrence of multi-drug-resistant malarial parasites ( Plasmodium falciparum ), the anti-malarial drug most effective against malaria is artemisinin, a natural product (sesquiterpene lactone endoperoxide) extracted from sweet wormwood ( Artemisia annua ). However, artemisinin is in short supply and unaffordable to most malaria patients. Artemisinin can be semi-synthesized from its precursor artemisinic acid, which can be synthesized from simple sugars using microorganisms genetically engineered with genes from A. annua . In order to develop an industrially competent yeast strain, detailed analyses of microbial physiology and development of gene expression strategies are required. Results Three plant genes coding for amorphadiene synthase, amorphadiene oxidase ( AMO or CYP71AV1 ), and cytochrome P450 reductase, which in concert divert carbon flux from farnesyl diphosphate to artemisinic acid, were expressed from a single plasmid. The artemisinic acid production in the engineered yeast reached 250 μg mL -1 in shake-flask cultures and 1 g L -1 in bio-reactors with the use of Leu2d selection marker and appropriate medium formulation. When plasmid stability was measured, the yeast strain synthesizing amorphadiene alone maintained the plasmid in 84% of the cells, whereas the yeast strain synthesizing artemisinic acid showed poor plasmid stability. Inactivation of AMO by a point-mutation restored the high plasmid stability, indicating that the low plasmid stability is not caused by production of the AMO protein but by artemisinic acid synthesis or accumulation. Semi-quantitative reverse-transcriptase (RT)-PCR and quantitative real time-PCR consistently showed that pleiotropic drug resistance ( PDR ) genes, belonging to the family of ATP-Binding Cassette (ABC) transporter, were massively induced in the yeast strain producing artemisinic acid, relative to the yeast strain producing the hydrocarbon amorphadiene alone. Global transcriptional analysis by yeast microarray further demonstrated that the induction of drug-resistant genes such as ABC transporters and major facilitator superfamily (MSF) genes is the primary cellular stress-response; in addition, oxidative and osmotic stress responses were observed in the engineered yeast. Conclusion The data presented here suggest that the engineered yeast producing artemisinic acid suffers oxidative and drug-associated stresses. The use of plant-derived transporters and optimizing AMO activity may improve the yield of artemisinic acid production in the engineered yeast.

Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development

From Plant to Yeast-Advances in Biosynthesis of Artemisinin

High-level semi-synthetic production of the potent antimalarial artemisinin

Production of the antimalarial drug precursor artemisinic acid in engineered yeast

Biotechnological Approaches for Production of Artemisinin, an Anti-Malarial Drug from Artemisia annua L

Advanced metabolic engineering strategies for increasing artemisinin yield in Artemisia annua L

Enhancing artemisinin content in and delivery from Artemisia annua: a review of alternative, classical, and transgenic approaches

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

Combined chemical transformation and biological transformation of artemisinin: A facile approach to diverse artemisinin derivatives

Cultivation and genetics of Artemisia annua L. for increased production of the antimalarial artemisinin

Molecular Farming in Artemisia annua, a Promising Approach to Improve Anti-malarial Drug Production

Compartmentalized Metabolic Engineering for Artemisinin Biosynthesis and Effective Malaria Treatment by Oral Delivery of Plant Cells

Arctigenin: Pharmacology, Total Synthesis, and Progress in Structure Modification

Increased artemisinin production in Artemisia annua L. by co-overexpression of six key biosynthetic enzymes

Selection and Clonal Propagation of High Artemisinin Genotypes of Artemisia annua

Successes of artemisinin elicitation in low-artemisinin producing Artemisia annua cell cultures constrained by repression of biosynthetic genes

Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid

Enhanced Antimalarial Activity of Extracts of Artemisia annua L. Achieved with Aqueous Solutions of Salicylate Salts and Ionic Liquids

Study towards improving artemisinin-based combination therapies

Isolation of Dihydroartemisinic Acid from Artemisia annua L. By-Product by Combining Ultrasound-Assisted Extraction with Response Surface Methodology

Engineering Nootkatone Biosynthesis in Artemisia Annua.